US Patent

US11633374 — Compositions and methods for treating epilepsy, seizures and other conditions

Formulation · Assigned to Tulex Pharmaceuticals Inc · Expires 2040-08-21 · 14y remaining

Vulnerability score 50/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects compositions for the liquid oral administration of topiramate and its salts for treating various conditions.

USPTO Abstract

Compositions are provided for the liquid oral administration of topiramate and its salts. The invention further provides methods for treating diseases and disorders using the compositions.

Drugs covered by this patent

Patent Metadata

Patent number
US11633374
Jurisdiction
US
Classification
Formulation
Expires
2040-08-21
Drug substance claim
No
Drug product claim
Yes
Assignee
Tulex Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.